Alnylam Pharmaceuticals (ALNY) Cash from Operations (2009 - 2026)
Alnylam Pharmaceuticals' Cash from Operations was $326.72 million in Q2 2026, up 151.7% from $129.81 million a year earlier and up 363.4% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Cash from Operations (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alnylam Pharmaceuticals' Cash from Operations was $911.81 million through Jun 30, 2026; for FY2025, it was $524.08 million.
- In earlier years, Cash from Operations was -$8.31 million in FY2024, $104.16 million in FY2023, -$541.27 million in FY2022 and -$641.69 million in FY2021.
- Quarterly Cash from Operations has moved between -$171.19 million (Q1 2022) and $359.41 million (Q3 2023) over five years.
- Compared with a year earlier, Cash from Operations was higher in three of the last four quarters, with growth averaging 192.9%.
- Per Business Quant data, ALNY's Cash from Operations in the three quarters before Q2 2026 was $70.5 million (Q1 2026), $163.56 million (Q4 2025) and $351.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 11.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.61 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 6.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.67 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.24 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.38 Bn |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn | 340.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 340.99 Mn |
| Jun 30, 2026 | 326.72 Mn |
| Mar 31, 2026 | 70.50 Mn |
| Dec 31, 2025 | 217.73 Mn |
| Sep 30, 2025 | 296.86 Mn |
| Jun 30, 2025 | 129.81 Mn |
| Mar 31, 2025 | -120.31 Mn |
| Dec 31, 2024 | -94.66 Mn |
| Sep 30, 2024 | 43.71 Mn |
| Jun 30, 2024 | 124.16 Mn |
| Mar 31, 2024 | -81.52 Mn |
| Dec 31, 2023 | -29.80 Mn |
| Sep 30, 2023 | 359.41 Mn |
| Jun 30, 2023 | -58.99 Mn |
| Mar 31, 2023 | -166.48 Mn |
| Dec 31, 2022 | -131.98 Mn |
| Sep 30, 2022 | -115.28 Mn |
| Jun 30, 2022 | -122.82 Mn |
| Mar 31, 2022 | -171.19 Mn |
| Dec 31, 2021 | -150.14 Mn |
API Access
Alnylam Pharmaceuticals Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();